Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Clinical cancer research (Print)")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4211

  • Page / 169
Export

Selection :

  • and

A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian CancerCHEON, Dong-Joo; YUNGUANG TONG; KARLAN, Beth Y et al.Clinical cancer research (Print). 2014, Vol 20, Num 3, pp 711-723, issn 1078-0432, 13 p.Article

A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaRIBRAG, Vincent; DUPUIS, Jehan; HATTEVILLE, Laurence et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 213-220, issn 1078-0432, 8 p.Article

A Phase I Dose-Finding Study of the Novel Toll-like Receptor8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or LymphomaNORTHFELT, Donald W; RAMANATHAN, Ramesh K; COHEN, Peter A et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3683-3691, issn 1078-0432, 9 p.Article

Accelerated Approval for Pertuzumab in the Neoadjuvant Setting: Winds of Change?ESSERMAN, Laura J; DEMICHELE, Angela.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3632-3636, issn 1078-0432, 5 p.Article

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung CancerPOLANSKI, Radostaw; HODGKINSON, Cassandra L; SMITH, Paul D et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 926-937, issn 1078-0432, 12 p.Article

Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of avβ6 Integrin in DCIS Identifies High-risk Patients and Predicts RecurrenceALLEN, Michael D; THOMAS, Gareth J; PENNINGTON, Caroline J et al.Clinical cancer research (Print). 2014, Vol 20, Num 2, pp 344-357, issn 1078-0432, 14 p.Article

Anti-VEGF Antibodies Mitigate the Development of Radiation Necrosis in Mouse BrainXIAOYU JIANG; ENGELBACH, John A; GARBOW, Joel R et al.Clinical cancer research (Print). 2014, Vol 20, Num 10, pp 2695-2702, issn 1078-0432, 8 p.Article

BCMab1, A Monoclonal Antibody against Aberrantly Glycosylated Integrin α3β1, Has Potent Antitumor Activity of Bladder Cancer In VivoCHONG LI; ZHAO YANG; YING DU et al.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 4001-4013, issn 1078-0432, 13 p.Article

BRaf and MEK Inhibitors Differentially Regulate Cell Fate and Microenvironment in Human Hepatocellular CarcinomaBREUNIG, Christian; MUELLER, Bernadett J; UMANSKY, Ludmila et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2410-2423, issn 1078-0432, 14 p.Article

Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted TherapiesMEADOR, Catherine B; MICHEEL, Christine M; VNENCAK-JONES, Cindy L et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2264-2275, issn 1078-0432, 12 p.Article

Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non-Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient BenefitKOEPPEN, Hartmut; WEI YU; LING FU et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4488-4498, issn 1078-0432, 11 p.Article

Blood mRNA Expression Profiling Predicts Survival in Patients Treated with TremelimumabSAENGER, Yvonne; MAGIDSON, Jay; FRIEDLANDER, Philip et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3310-3318, issn 1078-0432, 9 p.Article

Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose PersonalizationMcCUNE, Jeannine S; BEMER, Meagan J; BARRETT, Jeffrey S et al.Clinical cancer research (Print). 2014, Vol 20, Num 3, pp 754-763, issn 1078-0432, 10 p.Article

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNARICCARDO, Federica; LUSSICH, Selina; MARTANO, Marina et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3753-3762, issn 1078-0432, 10 p.Article

Cisplatin-Induced Renal Injury Is Independently Mediated by OCT2 and p53SPROWL, Jason A; LANCASTER, Cynthia S; CIARIMBOLI, Giuliano et al.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 4026-4035, issn 1078-0432, 10 p.Article

Clusterin Is a Gene-Specific Target of microRNA-21 in Head and Neck Squamous Cell CarcinomaMYDLARZ, Wojciech; UEMURA, Mamoru; MAMBO, Elizabeth et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 868-877, issn 1078-0432, 10 p.Article

Co-Clinical Trials Demonstrate Superiority of Crizotinib to Chemotherapy in ALK-Rearranged Non-Small Cell Lung Cancer and Predict Strategies to Overcome ResistanceZHAO CHEN; AKBAY, Esra; REIBEL, Jacob B et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1204-1211, issn 1078-0432, 8 p.Article

Companion Diagnostics: Has Their Time Come and Gone?HIRSCH, Fred R; BUNN, Paul A; HERBST, Roy S et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4422-4424, issn 1078-0432, 3 p.Article

Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and SorafenibWILSON, Melissa A; FENGMIN ZHAO; NATHANSON, Katherine L et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3328-3337, issn 1078-0432, 10 p.Article

Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K-Akt Oncogenic Dependence in Pancreatic Ductal AdenocarcinomaWONG, Matthew H; AIQUN XUE; JULOVI, Sohel M et al.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 4047-4058, issn 1078-0432, 12 p.Article

Cross-talk between EphA2 and BRaf/CRaf Is a Key Determinant of Response to DasatinibJIE HUANG; WEI HU; PECOT, Chad V et al.Clinical cancer research (Print). 2014, Vol 20, Num 7, pp 1846-1855, issn 1078-0432, 10 p.Article

DNA Topoisomerase III Alpha Regulates p53-Mediated Tumor SuppressionHSIEH, Mei-Yi; FAN, Jia-Rong; CHANG, Han-Wen et al.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1489-1501, issn 1078-0432, 13 p.Article

Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteePALLER, Channing J; BRADBURY, Penelope A; REEVES, Steven et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4210-4217, issn 1078-0432, 8 p.Article

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast CancerBEAVER, Julia A; JELOVAC, Danijela; CHU, David et al.Clinical cancer research (Print). 2014, Vol 20, Num 10, pp 2643-2650, issn 1078-0432, 8 p.Article

Discrete Molecular Classes of Ovarian Cancer Suggestive of Unique Mechanisms of Transformation and MetastasesGARDI, Nilesh L; DESHPANDE, Tejaswini U; KAMBLE, Swapnil C et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 87-99, issn 1078-0432, 13 p.Article

  • Page / 169